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Abstract
Polycystic ovary syndrome (PCOS) is a heritable 
endocrine disorder in women that causes irregular 
menses, hyperandrogenism, polycystic ovaries, 
and infertility. The first line therapy for ovulation 
induction in women with PCOS has been 
Clomiphene citrate (CC), but Letrozole has been 
considered as an alternative treatment. This 
review poses the following question: In women 
(18-40 years old) with Polycystic Ovary 
Syndrome, does Letrozole or Clomiphene Citrate 
provide better outcomes in treating infertility? 
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Symptoms
Ø Oligomenorrhea or amenorrhea
Ø Hirsutism
Ø Infertility and insulin resistance
Clomiphene citrate
Ø Selective estrogen receptor modulator
Ø Increased resistance 
Ø Negative side effects
Letrozole
Ø Aromatase inhibitor








Ø “PCOS” AND “Letrozole” OR “Clomiphene”
Ø “Letrozole” AND “Clomiphene”
Ø “PCOS” AND “Letrozole” AND “Clomiphene”
Inclusion Criteria 
Ø Controlled trials, randomized controlled trials, 
and prospective cohorts 
Ø Publication dates of 2009 or later
Exclusion Criteria 
Ø Systematic reviews
Ø Male participants 
Ø Female participants outside of the 18-40 years 
old range
Ø Population size was less than 100
Ø Studies that were conducted on animals
All studies found that Letrozole had 
statistically significantly better outcomes 
in pregnancy or a factor that could lead to 
better chances of pregnancy compared to 
CC.
Strengths
Ø 5/6 studies were RCTà eliminates bias in 
treatment assignment 
Ø Statistically significant results à all studies 
used p value < 0.05
Ø All studies had a sample size of over 100 
participants 
Ø 4/6 studies used a representative 
population
Limitations
Ø All studies started the medications on 
different days of a menstrual cycle 
Ø Variety of outcome measures 
Future research 
Ø Additional studies should be conducted 
that include anovulatory women with 
PCOS who are obese
Discussion Results 
In women (18-40 years old) with Polycystic Ovary Syndrome, does Letrozole or Clomiphene provide 
better outcomes in treating infertility?
The evidence supports that for women (18-
40 years old) with PCOS, Letrozole provides 
better outcomes in treating infertility 
compared to CC and should replace it as the 
first-line treatment
The six studies reviewed in this paper 
support the conclusion that when compared 
to CC, Letrozole significantly increases
Ø Pregnancy rates 
Ø Ovulation rates
Ø Rate of mono-follicular 
development
Ø Number of live births
Studies also show that Letrozole has less of 
a thinning effect of the endometrium 
compared to CC
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Study Dosing Schedule Outcomes 
1 50mg of CC
2.5mg of Letrozole 
Starting on day 2–4 of MP
Daily for 5 days 
Pregnancy, Time to pregnancy
2 100mg of CC
5mg of Letrozole 
Day 5 and 9 on MP Pregnancy, Ovulation 
3 100mg of CC
5mg of Letrozole 
Starting on day 2 of MP
Daily for 5 days 
Pregnancy, Ovulation, 
Endometrial thickness, Follicular 
rate 
4 50mg of CC
2.5mg of Letrozole 
Starting on day 3 of MP 
Daily for 5 days 
Live births, Ovulation, 
Pregnancy loss 
5 50mg of CC
2.5mg of Letrozole 
Starting on day 3–7 of MP
Daily for 5 days
Pregnancy, ovulation 
6 100mg of CC
5mg of Letrozole
40mg of Tamoxifen 
Starting on day 2–6 of MP
Daily for 5 days 
Pregnancy, Endometrial 
thickness 
